Montana hearing on HB205 spotlights constitutional, safety concerns over broad lethal-injection language

Representative Shannon Maness, sponsor of House Bill 205, opened a House Judiciary hearing saying the bill would "revise laws related to the death penalty" by changing statute language about lethal-injection drugs. "We're looking at House Bill 205, an act revising laws related to the death penalty," Representative Maness told the committee.

The bill would remove statutory language requiring an "ultra fast acting barbiturate" and replace it with a provision allowing the administration of "a substance or substances sufficient to cause death." Supporters who testified in the hearing said the change is intended to address a de facto moratorium on executions after a 2015 Montana court ruling that the state's prior protocol did not comply with statute; opponents said the rewrite is dangerously broad and likely to provoke constitutional challenges.

Why it matters: The change would remove a specific statutory description of drugs used in executions and give the Department of Corrections greater latitude to select drugs when executing a sentence. Opponents told the committee that broad language could permit methods or substances that violate the Eighth Amendment or Montana constitutional protections and that repeated litigation would be likely if the statute lacks guardrails.

In testimony opposing the bill, Alex Rate, deputy director and legal director of the American Civil Liberties Union of Montana, argued the statute risks constitutional violation and harms dignity protections in the Montana Constitution. "Capital punishment is brutal, barbaric, and not in keeping with evolving standards of decency," Rate told the committee, and he said HB205 "permits any substance or substances in lethal quantity to be administered sufficiently to cause death." Rate cited Montana constitutional provisions—article II, section 22 (cruel and unusual punishment) and article II, section 4 (dignity)—and court rulings discussing those protections.

Witnesses reiterated that a 2015 district-court ruling (Judge Jeffrey Sherlock) found Montana's then-protocol conflicted with the statute's ultra-fast requirement. Robin Maher, executive director of the Death Penalty Information Center, told the committee many states now face shortages and high costs for execution drugs and that pentobarbital and similar drugs have become difficult to obtain. "There is really no evidence to support the use of the death penalty as a deterrent," Maher said, and she explained several states have paid large sums for pentobarbital or otherwise altered protocols amid legal and supply challenges.

Several advocacy groups opposed the bill on moral and legal grounds. Jasmine Krotkov of Truth to Power, Reverend Sue DeBree, the Montana Catholic Conference's Matt Braower, Nicole Gomez of Catalyst Montana, and representatives of the Montana Innocence Project argued the bill would widen the methods available to carry out executions and risk administering cruel or arbitrary methods. Don Cape of the Montana Coalition for Safety and Justice, who participated both in-person and online, said his group "do[es] not oppose or support the death penalty" but called the bill "fatally flawed" because it lacks guardrails; Cape said the coalition submitted proposed amendments that might address the problem.

Montana Department of Corrections deputy director Eric Strauss described the department's current practical approach: the DOC has observed a de facto moratorium since 2015 and would be required under its protocol to engage a qualified medical professional to develop any lethal cocktail should statutory language change. Strauss said the agency has not identified specific drugs it could use now and that the lack of an "ultra fast" barbiturate previously required by statute is a key reason executions could not proceed.

Committee members pressed the sponsor and witnesses on specifics: what drugs might be used, whether paralytics could still be part of a protocol, who would administer and monitor the drugs, and the fiscal and litigation costs of resuming executions. Maher and witnesses pointed to nearly 100 documented "botched executions" in the modern era, wide variance in time from injection to death, and examples of high prices paid by other states (reported examples cited in testimony included Utah paying roughly $200,000 for a small quantity of pentobarbital and Idaho paying sizeable amounts over multiple years). Strauss confirmed DOC's protocol requires contracting with a qualified medical professional to develop and advise on any drug cocktail and that the agency has not researched specific replacement drugs as the moratorium has been in effect.

Representative Maness closed by urging the committee to separate the procedural change from the broader death-penalty debate and recommended the bill "do pass," saying the change would allow the Department of Corrections to use available substances and "the latest technology" should the state resume executions.

Ending: The hearing closed with no committee vote recorded on HB205 during this session. Several witnesses asked the committee to consider amendments that would place limits or "guardrails" on what could be administered; others urged rejection on moral or constitutional grounds. The record summarizes competing views about how to balance statutory clarity, constitutional constraints, supply realities, and public-policy considerations should the Legislature choose to change the statute.